Philip J Kuehl

13PUBLICATIONS
39CO-AUTHORS
Toxicology (incl. clinical toxicology)Powder and particle technologyStatistical and quantitative geneticsIndustrial microbiology (incl. biofeedstocks)Proteins and peptides
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 07, 2026
Preclinical Development of a Dry Powder Formulation of Loxapine for Intranasal Delivery.

|Nov 10, 2025
Spray-Drying Process Optimization and Modeling for an Inhaled Dry Powder of 5-Azacytidine for Treating Local and Metastatic Lung Cancer.

Rebekah M Anderson, Steven A Belinsky, Lindsey M Earnest

|Jul 21, 2025
Evaluation of singlicate vs duplicate analysis in ligand binding assays: a case study with IFN-γ in mouse and NHP models.

Ruwini D Rajapaksha, Freya van Kesteren, Philip J Kuehl

|Mar 13, 2025
iBCS: 4. Application of the Inhalation Biopharmaceutics Classification System to the Development of Orally Inhaled Drug Products.

Ben Forbes, Per Bäckman, Antonio Cabal

|Jul 17, 2024
Discovery of GS-7682, a Novel 4'-Cyano-Modified C-Nucleoside Prodrug with Broad Activity against Pneumo- and Picornaviruses and Efficacy in RSV-Infected African Green Monkeys.

Dustin S Siegel, Hon C Hui, Jared Pitts

|Apr 13, 2024
Effect of TRPV4 Antagonist GSK2798745 on Chlorine Gas-Induced Acute Lung Injury in a Swine Model.

Meghan S Vermillion, Nathan Saari, Mathieu Bray

Pageof 3

Frequent Collaborators

4 joint publications

Per Bäckman

4 joint publications

Jayne Hastedt

4 joint publications

Ben Forbes

2 joint publications

Hammad Irshad